This candidate seeks a position as a medical technologist utilizing their bachelor's degree in clinical laboratory science and MLS certification. They have over 2 years of experience as a generalist medical technologist performing laboratory procedures in various disciplines. Their education includes a BS in clinical laboratory science and MLS certification. They are skilled in clinical laboratory techniques, problem solving, communication, and working efficiently under pressure.
Presented by Ms. Hindler at the 40th Annual Symposium "Diagnostic and Clinical Challenges of 20th Century Microbes", held on Nov 18, 2010 in Philadelphia.
Presented by Ms. Hindler at the 40th Annual Symposium "Diagnostic and Clinical Challenges of 20th Century Microbes", held on Nov 18, 2010 in Philadelphia.
Improving Patient Safety, Inventory Management, Quality and Cost Savings via ...Charles J. DiComo, PhD
Like many health systems, WellSpan Health experienced frequent fluctuations in demand for platelet transfusions. Sudden increases required emergency shipments, while decreases led to waste.
Lab leadership needed an easier way to ensure the availability of safe platelet transfusions at all times.
The Pennsylvania-based integrated health system implemented
the Platelet PGD test in 2016 at its largest acute care facility,
WellSpan York Hospital. The testing enables the hospital to extend platelets to day six or seven by PGD testing for bacterial
contamination. In turn, this extended dating allows the hospital
to stabilize inventory and generate cost savings by significantly
reducing wastage.
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3pCCjPF
Ensure your Adeno-Associated Virus (AAV) is safe throughout its entire drug development journey. Learn methods that will help you speed to clinic, potentially treating diseases sooner and with greater effectiveness.
The potential of gene therapies to cure previously untreatable diseases has spurred the development of novel drugs, including those based on Adeno-Associated Virus (AAV). As with all biopharmaceuticals, it is important to identify and monitor the critical quality attributes (CQAs) of these products to ensure their safety and efficacy.
In this webinar, we will present a range of orthogonal methods to understand and define the CQAs of AAV products. These include assays for the confirmation of capsid protein identity and quantity, as well as the characterization of important product-related impurities, such as aggregates. Together these methods represent a comprehensive analytical testing package to support the characterization and lot release of AAV products.
In this webinar, you will learn:
• How to identify and monitor the critical quality attributes (CQAs) of your AAV therapy
• What assays to utilize to confirm capsid protein identity and quantity
• Why you need look to product characterization to identify and remove important product-related impurities
Presentation from 10/15/13 on innovative startup producing cost effective nano particle kits to get large amounts of DNA into cells without damaging them. Genetix Fusion LLC founder Mohit Patel explains how nanotech makes this possible and the enormous time and cost problems they're able to address. Join OpenlyDisruptive.org for live access to more disruptive innovation events.
A presentation about the recent developments in Rapid microbiological detection methods from LumiByte.
MuScan for instant single cell detection and the colony tracker for ultra fast antibiotic suseptibility testing.
Presented at the Health and Technology event in Papendal the netherlands september 2013
Automated system for bacterial identificationDEEKSHANT KUMAR
[DOWNLOAD IT OPEN IT WITH MICROSOFT POWERPOINT THEN YOU WILL BE ABLE TO UNDERSTAND THE TOPIC COVERED.]
1. WHOLE TEXT IS RELIABLE.
2. TEXT HAS BEEN TAKEN FROM STANDARD TEXT BOOK FOR MEDICAL MICROBIOLOGY.
3. SOME PICTURE HAS BEEN TAKEN FROM JOURNAL.
Automation in microbiology, changing concept and defeating challengesAyman Allam
A presentation about the automation in microbiology presented in 24th conference of the Egyptian Society of Medical Microbiology and immunology, 4/2017.
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene TherapiesMerck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3aeCPNB
Find out how we turn up the dial on quality control testing for cell and gene therapies through rapid methods for sterility, mycoplasma, and replication competent virus. We will review the current regulatory expectations as well as the benefits and limitations that come with each method.
Two of the biggest challenges with applying traditional quality control (QC) test methods to cell and gene therapies, is time to results, due to short shelf-life, and availability of sufficient sample, due to small production volumes.
So how can these challenges be overcome while still meeting regulatory expectations?
In this webinar we will discuss and review suitable methods for rapid testing of short-life cell and gene therapies that may also help conserve limited production material. We will look at benefits, limitations, and regulatory expectations for various QC needs including current and future rapid methods for sterility, mycoplasma and replication competent virus.
In this webinar, you will learn:
• Why the shelf life of a cell or gene therapy product may impact your QC testing strategy
• Current regulatory expectations surrounding rapid methods for sterility, mycoplasma and replication competent virus
• Potential impacts of pursuing a non-optimal QC testing strategy
In this file, you can ref resume materials for medical such as resume tips, resume samples, cover letter samples, types of interview questions, medical situational interview, medical behavioral interview…
Improving Patient Safety, Inventory Management, Quality and Cost Savings via ...Charles J. DiComo, PhD
Like many health systems, WellSpan Health experienced frequent fluctuations in demand for platelet transfusions. Sudden increases required emergency shipments, while decreases led to waste.
Lab leadership needed an easier way to ensure the availability of safe platelet transfusions at all times.
The Pennsylvania-based integrated health system implemented
the Platelet PGD test in 2016 at its largest acute care facility,
WellSpan York Hospital. The testing enables the hospital to extend platelets to day six or seven by PGD testing for bacterial
contamination. In turn, this extended dating allows the hospital
to stabilize inventory and generate cost savings by significantly
reducing wastage.
Unveiling the Potential of your AAV Gene Therapy: Orthogonal methods to under...Merck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3pCCjPF
Ensure your Adeno-Associated Virus (AAV) is safe throughout its entire drug development journey. Learn methods that will help you speed to clinic, potentially treating diseases sooner and with greater effectiveness.
The potential of gene therapies to cure previously untreatable diseases has spurred the development of novel drugs, including those based on Adeno-Associated Virus (AAV). As with all biopharmaceuticals, it is important to identify and monitor the critical quality attributes (CQAs) of these products to ensure their safety and efficacy.
In this webinar, we will present a range of orthogonal methods to understand and define the CQAs of AAV products. These include assays for the confirmation of capsid protein identity and quantity, as well as the characterization of important product-related impurities, such as aggregates. Together these methods represent a comprehensive analytical testing package to support the characterization and lot release of AAV products.
In this webinar, you will learn:
• How to identify and monitor the critical quality attributes (CQAs) of your AAV therapy
• What assays to utilize to confirm capsid protein identity and quantity
• Why you need look to product characterization to identify and remove important product-related impurities
Presentation from 10/15/13 on innovative startup producing cost effective nano particle kits to get large amounts of DNA into cells without damaging them. Genetix Fusion LLC founder Mohit Patel explains how nanotech makes this possible and the enormous time and cost problems they're able to address. Join OpenlyDisruptive.org for live access to more disruptive innovation events.
A presentation about the recent developments in Rapid microbiological detection methods from LumiByte.
MuScan for instant single cell detection and the colony tracker for ultra fast antibiotic suseptibility testing.
Presented at the Health and Technology event in Papendal the netherlands september 2013
Automated system for bacterial identificationDEEKSHANT KUMAR
[DOWNLOAD IT OPEN IT WITH MICROSOFT POWERPOINT THEN YOU WILL BE ABLE TO UNDERSTAND THE TOPIC COVERED.]
1. WHOLE TEXT IS RELIABLE.
2. TEXT HAS BEEN TAKEN FROM STANDARD TEXT BOOK FOR MEDICAL MICROBIOLOGY.
3. SOME PICTURE HAS BEEN TAKEN FROM JOURNAL.
Automation in microbiology, changing concept and defeating challengesAyman Allam
A presentation about the automation in microbiology presented in 24th conference of the Egyptian Society of Medical Microbiology and immunology, 4/2017.
Turning up the Compen-DIAL: Rapid Test Methods for Cell & Gene TherapiesMerck Life Sciences
Watch the presentation of this webinar here: https://bit.ly/3aeCPNB
Find out how we turn up the dial on quality control testing for cell and gene therapies through rapid methods for sterility, mycoplasma, and replication competent virus. We will review the current regulatory expectations as well as the benefits and limitations that come with each method.
Two of the biggest challenges with applying traditional quality control (QC) test methods to cell and gene therapies, is time to results, due to short shelf-life, and availability of sufficient sample, due to small production volumes.
So how can these challenges be overcome while still meeting regulatory expectations?
In this webinar we will discuss and review suitable methods for rapid testing of short-life cell and gene therapies that may also help conserve limited production material. We will look at benefits, limitations, and regulatory expectations for various QC needs including current and future rapid methods for sterility, mycoplasma and replication competent virus.
In this webinar, you will learn:
• Why the shelf life of a cell or gene therapy product may impact your QC testing strategy
• Current regulatory expectations surrounding rapid methods for sterility, mycoplasma and replication competent virus
• Potential impacts of pursuing a non-optimal QC testing strategy
In this file, you can ref resume materials for medical such as resume tips, resume samples, cover letter samples, types of interview questions, medical situational interview, medical behavioral interview…
Current CV .
My objective is to obtain a rewarding and challenging research scientist position where my background and experience will contribute to the success of a growing company or research center.
Currently, I am a Senior Associate Scientist at Amgen Inc. and certified Molecular Biologist with the American Society of Clinical Pathology MB (ASCP). I have more than 10 years of experience in the biotechnology/ pharmaceutical industry. I am highly proficient in various lab techniques, technologies, and automation. I demonstrated consistent success in the execution of assay development and method validation activities supporting clinical stage programs within GCP and GLP regulated environments. I possess extensive experience in optimization and validation of drug potency assays (ELISA and cell based assays), protein purification and characterization, and DNA/RNA extraction and quantitation. I am a subject matter expertise in the areas of human and rodent cell lines propagation and tissue dis-aggregation. I have proven operational capabilities in the establishment of standard operating procedures to ensure our laboratory meets regulatory and business requirements.
I am a self-motivated professional who works effectively as an individual contributor or within a team matrix. As a quick learner, I can efficiently deliver results, easily adapt to changing environment and provide fresh ideas. My strengths include statistical analysis/guidance, report writing, and communication.
Thank you in advance for your consideration. Please feel free to call me at (805-990-6258), or by e-mail at (mahawally46@gmail.com) if you have questions or would like a list of references.
Sincerely,
Maha Rizk
1. OBJECTIVE
· Utilize bachelor’s degree and certification to find a medical technologist position.
· Excellent clinical laboratory skills, with commendable problem-solving and communication
skills.
· Accurate, consistent, diligent and focused on the timely, quality completion of all lab
procedures. Work well under pressure and time constraints within high-volume environments.
EDUCATION
B.S. Clinical Laboratory Science, The University of Texas at Austin, Austin, TX, August 2011.
MLS, Tarleton State University, Fort Worth, TX, November 2010
PROFESSIONAL CERTIFICATION
MLS, ASCP Certified, 2010
PROFESSIONAL EXPERIENCE
Lab Medical Technologist- Generalist
09/2012-Present, Deaconess Medical Center, Spokane, WA
Perform laboratory procedures in chemistry, hematology, urinalysis, microbiology, blood bank
and immunoassay used in the diagnosis, treatment and prevention of disease. Verify, record and
report lab results on all performed tests. Ensure compliance with government requirements,
hospital policies and laboratory procedures. Perform and evaluate QC and calibrations. Perform
daily and as needed maintenance on analyzers. Perform CAP proficiency testing.
Analyzers Used: Hologic TLi Fetal Fibronectin, iSTAT for ionized calcium, Advanced Micro-
Osmometer Model 3MO, Dimension EXL with LM, Architect Plus i1000SR, TDX for methotrexate,
Clinitek 500, XN-1000, Siemens BCS, eXcyte M (ESR), PFA 100, VerifyNow for aspirin and PRU
test, pH meter, Sofia for rapid Influenza identification
Completed advanced training for Sysmex XN1000 and trained peers in the proper use of new
functions and new CAP requirements.
2. Manual Testing Performed: CSF & BF testing, K-B stain, PF4 HIT, qualitative pregnancy tests, iron
stain, eos stain, cryoglobulin, myoglobin, APT test, Amnisure, reditTest, Sure-Vue Mono,
Gastroccult, BinaxNow RSV, Acceava Strep A; Direct Coombs, ABO, RH, and Indirect Coombs by
gel method
Lab Medical Technologist- Core Lab
01/2011-08/2012, John Peter Smith Hospital, Fort Worth, TX
Perform laboratory procedures in chemistry, hematology, urinalysis, and immunoassay used in
the diagnosis, treatment and prevention of disease. Verify, record and report lab results on all
performed tests. Ensure compliance with government requirements, hospital policies and
laboratory procedures. Perform and evaluate QC and calibrations. Perform daily, weekly, and
monthly maintenance on analyzers. Perform CAP proficiency testing.
Analyzers Used: Vista 3000T, Advanced Instruments Osmometer Model 3320, Roche AVL,
Centaur XP, STA-R Evolution, ESR Stat Plus, Iris, Hemocue, PFA100, Sysmex XE2100 and XE5000,
Cellavision DM96
Completed advanced training for Sysmex XE5000 and trained peers in the proper use of new
functions and new CAP requirements.
Manual Testing Performed: BF crystals and all other CSF & BF testing, eosmear, FDP, K-B stain,
PF4 HIT, qualitative pregnancy tests
PRN Lab Medical Technologist-Bacteriology
01/2012- 08/2012, John Peter Smith Hospital, Fort Worth, TX
Ensure quality of specimen. Plate specimens and evaluate gram stains. Read plates and identify
pathogens for blood, CSF, stool, urine, respiratory, anaerobic, wound, and group B strep
specimens. Prepare, stain, and identify virology cultures, and antinuclear & anti-dsDNA patterns.
Perform CAP proficiency testing.
Analyzers Used: VersaTrek, Phoenix 100, Vidas, Etimax 3000, GeneXpert
Manual Testing Performed: Clotest, rapid HIV, hemoccult, rapid mononucleosis, rapid
cryptococcus, VDRL, RPR, PBP2a (MRSA), RapID Yeast Plus, BBL Anaerobe and N/H crystals,
Microscan, C. diff, Virology using FreshCells & their staining with Elvis (HSV), D3 DFA (respiratory
viruses and CMV), and D3 IFA (enterovirus), fluorescent microscopy, ANA and DNA staining
3. Clinical Training
05/2010-11/2010, John Peter Smith Hospital, Fort Worth, TX
Rotated in Clinical Chemistry, Hematology, Microbiology, Serology, and Blood Bank laboratories
Operated and/or Observed: Sysmex XE2100, STA-R Evolution, Vista, Phoenix, MGIT
Performed: parasitology and mycobacterium preparations, body fluid counts, WBC differentials,
identification of microbiology cultures, blood cultures, cross matches, component preparation,
absorptions, elutions, cell panels, and chemistry assays
07/2010, Carter Blood Reference Laboratory, Bedford, TX
Rotated in Blood Bank laboratory
Performed: cross matches, component preparation, absorptions, elutions, and cell panels
LIS Experience: Cerner Classic, SCC Soft, Meditech
Available for all shifts and extended work hours.